138 related articles for article (PubMed ID: 10505768)
21. Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond.
Montalban C; Norman F
Expert Rev Anticancer Ther; 2006 Mar; 6(3):361-71. PubMed ID: 16503853
[TBL] [Abstract][Full Text] [Related]
22. Is there a role for a maintenance rituximab in indolent lymphoproliferative diseases other than follicular lymphoma?
Moccia AA; Zucca E; Ghielmini M
Leuk Lymphoma; 2017 Jan; 58(1):30-36. PubMed ID: 27813427
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of isolated cutaneous relapse of follicular lymphoma with rituximab.
Ferrer A; López-Guillermo A; Montoto S; Estrach T; Colomo L; Montserrat E
Ann Hematol; 2001 Aug; 80(8):479-81. PubMed ID: 11563595
[TBL] [Abstract][Full Text] [Related]
24. Follicular lymphoma: emerging therapeutic strategies.
Kenkre VP; Kahl BS
Expert Rev Hematol; 2010 Aug; 3(4):485-95. PubMed ID: 21083037
[TBL] [Abstract][Full Text] [Related]
25. Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas.
Ferreri AJ; Govi S; Colucci A; Crocchiolo R; Modorati G
Ophthalmology; 2011 Jan; 118(1):24-8. PubMed ID: 20709407
[TBL] [Abstract][Full Text] [Related]
26. Rituximab as maintenance therapy for patients with follicular lymphoma.
Vidal L; Gafter-Gvili A; Leibovici L; Shpilberg O
Cochrane Database Syst Rev; 2009 Apr; (2):CD006552. PubMed ID: 19370640
[TBL] [Abstract][Full Text] [Related]
27. Follicular lymphoma: today's treatments and tomorrow's targets.
Aurora V; Winter JN
Expert Opin Pharmacother; 2006 Jul; 7(10):1273-90. PubMed ID: 16805715
[TBL] [Abstract][Full Text] [Related]
28. A systematic overview of chemotherapy effects in indolent non-Hodgkin's lymphoma.
Brandt L; Kimby E; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):213-23. PubMed ID: 11441933
[TBL] [Abstract][Full Text] [Related]
29. Rituximab therapy for indolent non-Hodgkin's lymphoma.
Hagenbeek A; Czuczman MS; Ghielmini M; Herold M; Kimby E; Solal-Céligny P; Unterhalt M
Anticancer Drugs; 2002 Nov; 13 Suppl 2():S11-7. PubMed ID: 12710586
[TBL] [Abstract][Full Text] [Related]
30. [Development of monoclonal antibody therapy for malignant lymphoma].
Ogura M
Nihon Rinsho; 2002 Mar; 60(3):505-16. PubMed ID: 11904966
[TBL] [Abstract][Full Text] [Related]
31. Radiolabeled and native antibodies and the prospect of cure of follicular lymphoma.
Buchegger F; Press OW; Delaloye AB; Ketterer N
Oncologist; 2008 Jun; 13(6):657-67. PubMed ID: 18586921
[TBL] [Abstract][Full Text] [Related]
32. 'Watch and wait' as initial management for patients with follicular lymphomas: still a viable strategy?
Hagemeister FB
BioDrugs; 2012 Dec; 26(6):363-76. PubMed ID: 23057946
[TBL] [Abstract][Full Text] [Related]
33. Rituximab maintenance for follicular lymphoma.
Vidal L; Gafter-Gvili A; Shpilberg O
Nat Rev Clin Oncol; 2010 Mar; 7(3):1; author reply 1. PubMed ID: 20222179
[No Abstract] [Full Text] [Related]
34. [Anti-CD20 in hematologic oncology].
Milpied N
Presse Med; 2009 May; 38(5):788-98. PubMed ID: 19297126
[TBL] [Abstract][Full Text] [Related]
35. Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma.
Zinzani PL; Pulsoni A; Perrotti A; Soverini S; Zaja F; De Renzo A; Storti S; Lauta VM; Guardigni L; Gentilini P; Tucci A; Molinari AL; Gobbi M; Falini B; Fattori PP; Ciccone F; Alinari L; Martelli M; Pileri S; Tura S; Baccarani M
J Clin Oncol; 2004 Jul; 22(13):2654-61. PubMed ID: 15159414
[TBL] [Abstract][Full Text] [Related]
36. [Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -- results of a prospective randomized study of the German Low-Grade Lymphoma Study Group].
Forstpointner R; Hänel A; Repp R; Hermann S; Metzner B; Pott C; Hartmann F; Rothmann F; Böck HP; Wandt H; Unterhalt M; Hiddemann W
Dtsch Med Wochenschr; 2002 Oct; 127(43):2253-8. PubMed ID: 12397539
[TBL] [Abstract][Full Text] [Related]
37. Biologic therapy for lymphoma.
Bendandi M; Longo DL
Curr Opin Oncol; 1999 Sep; 11(5):343-50. PubMed ID: 10505770
[TBL] [Abstract][Full Text] [Related]
38. Rituximab Maintenance Strategy in Advanced Follicular Lymphoma: Facts and Controversies.
Milunović V; Bogeljić Patekar M; Jakubac KM; Mandac Rogulj I; Radić-Krišto D; Planinc-Peraica A; Ostojić Kolonić S
Acta Clin Croat; 2017 Mar; 56(1):143-156. PubMed ID: 29120553
[TBL] [Abstract][Full Text] [Related]
39. Rituximab maintenance therapy in follicular lymphoma comes of age.
Hiddemann W
Leuk Res; 2006 Mar; 30 Suppl 1():S1-2. PubMed ID: 16750672
[No Abstract] [Full Text] [Related]
40. Current treatment of follicular low-grade lymphomas.
Peterson BA
Semin Oncol; 1999 Oct; 26(5 Suppl 14):2-11. PubMed ID: 10561012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]